# Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients

> **NCT01131000** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 123 (actual)

## Conditions studied

- Fever

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Ibuprofen
- **DRUG:** Ibuprofen
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT01131000
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2010-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131000, "Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01131000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*